PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
National association representing Americas pharmacy benefit managers.
The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 20 of its records are shown together here.
These two are not added together. An organisation lobbying for itself reports its own spending, and the firms it retains report what they were paid; the rules ask the first to include the second, but filings do not always do so and a filing gives no way to tell. Each is shown as reported.
Reported lobbying by year
Filings
| Filing | Filed by | Amount |
|---|---|---|
|
3rd Quarter - Report 3rd Quarter 2026
|
EMERGENT STRATEGIES | $60,000 reported |
|
3rd Quarter - Termination (No Activity) 3rd Quarter 2026
|
FORWARD GLOBAL | — reported |
|
3rd Quarter - Report 3rd Quarter 2026
|
RED+BLUE STRATEGIES | $60,000 reported |
|
3rd Quarter - Report 3rd Quarter 2026
|
FIERCE GOVERNMENT RELATIONS | $60,000 reported |
|
3rd Quarter - Report 3rd Quarter 2026
|
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION | $3,203,049 reported |
|
3rd Quarter - Report 3rd Quarter 2026
|
CONTINENTAL STRATEGY, LLC | $90,000 reported |
|
3rd Quarter - Report 3rd Quarter 2026
|
RYAN COSTELLO STRATEGIES | $50,000 reported |
|
3rd Quarter - Report 3rd Quarter 2026
|
THE GIBSON GROUP, LLC | $50,000 reported |
|
2nd Quarter - Report (No Activity) 2nd Quarter 2026
|
FORWARD GLOBAL | — reported |
|
2nd Quarter - Report 2nd Quarter 2026
|
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION | $3,282,990 reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION In-house | 77 | $110,339,793 |
| RED+BLUE STRATEGIES | 63 | $3,910,000 |
| BLUESTONE STRATEGIES, LLC | 54 | $2,870,000 |
| FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) | 14 | $720,000 |
| JENNINGS POLICY STRATEGIES | 11 | $650,000 |
| RYAN COSTELLO STRATEGIES | 13 | $640,000 |
| EMERGENT STRATEGIES | 10 | $580,000 |
| CONTINENTAL STRATEGY, LLC | 6 | $570,000 |
| FIERCE GOVERNMENT RELATIONS | 9 | $500,000 |
| BOCKORNY GROUP, INC. | 7 | $480,000 |
| BELLEAIRE CONSULTING | 8 | $340,000 |
| MERCURY PUBLIC AFFAIRS, LLC | 3 | $240,000 |
| 1607 STRATEGIES, LLC | 7 | $180,000 |
| THE GIBSON GROUP, LLC | 4 | $180,000 |
| BOSE PUBLIC AFFAIRS GROUP | 11 | $150,000 |
| COLAS & ASSOCIATES, LLC | 4 | $90,000 |
| FORWARD GLOBAL | 7 | $60,000 |
| HAYES HEALTH POLICY STRATEGIES, PLLC | 1 | $60,000 |
| QUADRIPOINT STRATEGIES LLC | 6 | $20,000 |
| MANATT, PHELPS, AND PHILLIPS | 3 | $10,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Health Issues | HCR | 271 |
| Pharmacy | PHA | 256 |
| Medicare/Medicaid | MMM | 230 |
| Postal | POS | 19 |
| Labor Issues/Antitrust/Workplace | LBR | 12 |
| Trade (domestic/foreign) | TRD | 9 |
| Defense | DEF | 7 |
| Budget/Appropriations | BUD | 4 |
| Insurance | INS | 2 |
| Accounting | ACC | 1 |
| Transportation | TRA | 1 |
| Manufacturing | MAN | 1 |
| Taxation/Internal Revenue Code | TAX | 1 |
| Medical/Disease Research/Clinical Labs | MED | 1 |
Bills named in its filings
Bill numbers found in the filers' descriptions, most often named first.
| Bill | Congress | Times named |
|---|---|---|
| S. 637 | 115th | 56 |
| S. 127 | 118th | 48 |
| S. 771 | 115th | 48 |
| S. 1967 | 118th | 45 |
| H.R. 5378 | 118th | 44 |
| S. 1339 | 118th | 42 |
| H.R. 244 | 114th | 41 |
| H.R. 3561 | 118th | 38 |
| S. 476 | 116th | 35 |
| H.R. 1946 | 112th | 35 |
| S. 2973 | 118th | 34 |
| H.R. 6 | 114th | 32 |
| H.R. 793 | 114th | 32 |
| H.R. 804 | 114th | 29 |
| H.R. 1367 | 113th | 29 |
| S. 927 | 119th | 28 |
| S. 3430 | 118th | 27 |
| H.R. 1939 | 115th | 26 |
| S. 150 | 118th | 25 |
| H.R. 1035 | 116th | 24 |
| H.R. 1034 | 116th | 24 |
| H.R. 803 | 116th | 24 |
| S. 640 | 116th | 24 |
| H.R. 3 | 116th | 24 |
| H.R. 748 | 116th | 24 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.